Recombinant parainfluenza virus 3 (rPIV3) is being developed as a vector to express foreign genes as a bivalent or multivalent live attenuated virus vaccine. In the present study, we examined the effect of inserted foreign sequence on virus replication in vitro and in vivo, focusing on the parameter of insert length. In one type of construct, foreign sequence of increasing length was flanked by PIV3 transcription signals and inserted as an additional gene unit (GU insert) between the HN and L genes, so that one additional mRNA would be made. In a second type of construct, foreign sequence was inserted into the downstream NCR (NCR insert) of the HN gene, so that the number of encoded mRNAs remained unchanged. In each case, the foreign sequence was designed to lack any significant open reading frame, which permitted an evaluation of the effect of insert length on replication independent of an effect of an expressed protein. The GU or NCR insert sizes ranged from 168 nucleotides (nt) to 3918 nt. rPIV3s containing GU insertions of up to 3918 nt in length, the largest size tested, were viable and replicated efficiently at permissive temperatures in vitro, but a reduction in plaque size was seen at 39°C and 40°C. The rPIV3 with a 3918-nt GU insertion was restricted in replication in the upper (fivefold) and lower (25-fold) respiratory tracts of hamsters. Although a 1908-nt GU insertion did not significantly modify replication of wild-type PIV3 in vitro or in vivo, its introduction significantly augmented the level of temperature sensitivity (ts) and attenuation (att) specified by three mutations in the L protein of a cold-passaged attenuated PIV3 vaccine virus. rPIV3s bearing a 3126-or 3894-nt NCR insertion exhibited in vitro and in vivo phenotypes like those of the rPIV3s bearing similar-sized GU insertions. These findings indicate that rPIV3s whose genome length has been increased by more than 3000 nt by either a GU or an NCR insertion exhibit an unexpected host-range phenotype, that is, efficient replication in vitro but restricted replication in hamsters, especially in the lower respiratory tract. Furthermore, these effects were greatly enhanced when the rPIV3 backbone contained other ts or att mutations. The implications of these findings for the use of single-stranded, negative-sense RNA viruses as vectors for vaccines are discussed.
INTRODUCTION
The ability to recover infectious virus from cDNAs of single-stranded, negative-sense RNA viruses belonging to the Mononegavirales order of viruses, referred to as mononegaviruses, has made it possible to explore the use of these viruses as vectors for the expression of foreign antigens for use as vaccines (Bukreyev et al., 1996 Finke and Conzelmann, 1997; Hasan et al., 1997; He et al., 1997; Jin et al., 1998; Johnson et al., 1997; Kahn et al., 1999; Kretzschmar et al., 1997; Mebatsion et al., 1996; Moriya et al., 1998; Roberts et al., , 1999 Schnell et al., 1996a Schnell et al., ,b, 1997 Spielhofer et al., 1998; Yu et al., 1997) . When placed under the control of viral transcription gene-start (GS) and gene-end (GE) signals and inserted into the gene order, the foreign gene is expressed as a separate mRNA, and a high level of protein expression occurs.
One concern that has arisen for the use of mononegaviruses as vectors is that foreign gene expression can decrease replication in vitro, complicating the production of vaccine virus. Certain foreign proteins appear to be toxic and indirectly decrease viral replication, such as in the case of VSV expressing the influenza virus NA or the measles virus F protein (Kretzschmar et al., 1997; Schnell et al., 1996a) . More generally, the insertion of an additional gene can decrease the efficiency of transcription of downstream genes. An increase in genome length, independent of the number of transcriptional units, also might reduce the efficiency of virus growth. For example, Sendai virus-bearing gene inserts ranging in size from 0.7 kb up to 3.2 kb was partially defective for replication in vitro and in vivo (Sakai et al., 1999) . The degree of impairment was in direct proportion to the size of the protein expressed, but it was not determined whether this was a function of the expressed protein or the size of the gene or both.
Here we examined several aspects of the use of recombinant human PIV3 as a vector of foreign sequence. Infection by PIV3 in infancy or early childhood can result in severe lower respiratory tract disease and is a significant cause of hospitalization due to respiratory illness in infants . There is, therefore, a clear need for a PIV3 vaccine. PIV3 is an enveloped virus that contains a single-stranded, negative-sense RNA genome 15462 nt in length. The 3Ј and 5Ј ends of the viral genome contain extragenic leader and trailer regions that possess promoters required for replication and transcription. The PIV3 genetic map is 3Ј leader-N-P(C/D/V)-M-F-HN-L-5Ј trailer. Transcription initiates at the 3Ј end and proceeds by a sequential stop-start mechanism that is guided by short conserved motifs found at the gene boundaries. The upstream end of each gene contains a GS signal, which directs initiation of its respective mRNA. The downstream terminus of each gene contains a GE motif, which directs polyadenylation and termination, and each gene is separated by a conserved intergenic trinucleotide that also is thought to play a role in transcription .
A number of attributes make PIV3 an attractive choice as a vector for heterologous antigens: (1) our ability to recover infectious PIV3 from cDNA (Durbin et al., 1997) , (2) the availability of attenuated derivatives of PIV3 that are currently in clinical trials (Karron et al., 1995b; Skiadopoulos et al., 1998 Skiadopoulos et al., , 1999a , (3) the ability of an attenuated PIV3 vaccine candidate to replicate in the respiratory tract, in the presence of physiological amounts of maternally acquired antibodies , (4) the induction of strong systemic and local immune responses by PIV3 , and (5) the availability of an antigenic chimeric PIV3 bearing the PIV1 F and HN protective antigens (Skiadopoulos et al., 1999c; Tao et al., 1998) . A cold passaged (cp) PIV3, termed cp45, has been shown to be safe and immunogenic in humans (Belshe and Hissom, 1982; Karron et al., 1995a,b) , and its use as a vector to immunize against an additional human pathogen would be practical, because a series of rPIV3s bearing various combinations or all of the cp45 mutations has been described (Skiadopoulos et al., 1999a) and is immediately available for constructing attenuated PIV3 derivatives.
In our effort to explore the use of PIV3 as a vector, we first sought to define the relative contribution of the length of a transcription unit on virus replication in vitro and in vivo. The gene unit (GU) insertions of various lengths containing GS and GE sequences were engineered to lack a significant open reading frame (ORF), which permitted an evaluation of the effect of GU length on replication independent of an effect of an expressed protein. Control viruses bearing 3Ј noncoding region (NCR) insertions that increased the length of the genome without increasing the total number of transcriptional units were also evaluated. These rPIV3s with GU or NCR insertions were evaluated for rate and level of replication in vitro, for level of temperature sensitivity of plaque formation in vitro, and for their level of replication in the upper and lower respiratory tracts of hamsters.
RESULTS

Construction of cDNAs encoding rPIV3 viruses containing GU or NCR inserts of increasing lengths
A series of rPIV3s was designed that contained inserts of increasing length of sequence derived from a heterologous virus, RSV (Fig. 1, Table 1 ). One type of insert (designated GU) was designed so that the foreign sequence was flanked by PIV3 GS and GE transcription signals to form a gene unit that would encode an additional mRNA (Fig. 1A) . The GU inserts were placed between the HN and L genes. To distinguish between effects due to increased genome length versus the synthesis of an additional mRNA, a second type of insert (designated NCR) was designed. These inserts did not contain transcription signals and were placed in the downstream 3Ј NCR of the HN gene in the same site used for the GU inserts (Fig. 1B) . Thus the number of encoded mRNAs was unchanged, although the downstream NCR of the HN mRNA was increased in size. The foreign sequence was inserted in an orientation such that all reading frames contained multiple stop codons so that a functional protein could not be produced. Because the inserted RSV sequence was designed to lack a significant ORF, phenotypic differences resulting from the insertion could be attributed to the length of the insert and not to an effect of an expressed protein on virus replication. The GU inserts ranged in size from 168 to 3918, whereas the NCR inserts ranged from 258 to 3894 nt. In all cases, the final antigenome length was a multiple of six, conforming to the rule of six.
The use of rPIV3 as a vector might require the inclusion of attenuating mutations in the PIV3 backbone. We therefore inserted a 1908-nt GU into rcp45 L , which encodes three amino acid changes in the L protein that confer the temperature sensitivity (ts) and attenuation (att) phenotypes (Skiadopoulos et al., 1998) , and we evaluated the effect of the insertion on these phenotypes. The 1908-nt GU insert was chosen because its size is representative of many paramyxovirus glycoprotein genes.
Recovery of rPIV3 and evaluation in vitro
The various antigenomic cDNAs were used to direct the recovery of rPIV3 as described previously. In each case, rPIV3 was recovered successfully. In initial amplification, the various rPIV3s grew to similar titer (note that the viruses were recovered and propagated at 32°C, which is a permissive temperature for each virus). RNA was isolated from each recovered virus and analyzed by RT-PCR to confirm the presence of an insert of the appropriate size in genomic RNA (Fig. 2) . In addition, the RT-PCR products were analyzed by restriction enzyme digestion and partial nucleotide sequencing to confirm genome structure. Also, the presence of the three ts mutations in rcp45 L was confirmed (not shown). Thus rPIV3 containing an NCR or a GU insert of up to 3894 and 3918 nt in length, respectively, representing more than 25% of the 15642-nt wild-type (wt) PIV3 genome, was viable and grew efficiently in vitro.
The multistep growth kinetics of representative rPIV3 viruses were evaluated (Fig. 3) . In Fig. 3A , wt rPIV3 was compared with rPIV3 bearing GU inserts of 168, 1908, and 3918 nt. The mutant viruses replicated with kinetics similar to that of wild-type virus, although the peak titer of r3918 GU insert was sixfold lower than rPIV3 wt. Figure   3B shows a comparison of the growth of wt rPIV3 and two attenuated recombinant viruses, namely rcp45 L , and its derivative, rcp45 L , bearing the 1908-nt GU insert. Insertion of the 1908 GU did not decrease the rate of replication of rcp45 L , but the peak titer of rcp45 L /1908 was sixfold lower than that of rcp45 L . Figure 3C compares rPIV3 wt with rPIV3s bearing NCR inserts of 258, 1404, and 3845 nt. The kinetics of replication of rPIV3 wt and rPIV3s bearing the NCR inserts were similar, and the peak titer of the rPIV3 3845 NCR insertion mutant was only fivefold less than that of rPIV3 wt.
Next, the wild-type and mutant viruses were evaluated for their efficiency of plaque formation over a range of temperatures (Table 2) . At 32°C, rPIV3 bearing GU or NCR inserts of varying sizes had plaque morphologies that were the same as that of wt rPIV3. For the rPIV3 FIG. 1. Location and construction of GU or NCR insertions. The downstream (3Ј) NCR of the PIV3 HN gene was modified to contain a StuI restriction site at antigenomic positions 8598-8603, which was then used to construct GU and NCR inserts. Cis-acting transcriptional signal sequences [i.e., GE, intergenic (IG), and GS signal sequences] are indicated. (A) For GU inserts, an oligonucleotide duplex specifying the HN GE, IG, and GS signal sequences, as well as the unique restriction enzyme recognition sequences, are shown inserted into the introduced StuI restriction site. A restriction fragment from an RSV antigenome plasmid was cloned into the HpaI site. As necessary, a short oligonucleotide duplex was inserted into the MluI site of the multiple cloning site, so that the total length of the insert would conform to the rule of six. The final size of the GU inserts ranged from 168 to 3918 nt. Note that rPIV3 containing a GU insert would encode an additional mRNA of increasing size. (B) For NCR inserts, an oligonucleotide duplex containing MluI, HpaI, BstBI, and SacI restriction sites was cloned into the StuI site, and the HpaI and MluI sites were used to accept RSV-specific sequence and synthetic oligonucleotides as described above and indicated in Table 1 . The final size of the NCR inserts ranged from 258 to 3894 nt. Note that rPIV3 containing an NCR insert would encode an HN mRNA whose NCR was of increasing length, but the number of encoded mRNAs would be unchanged.
bearing GU inserts, the efficiency of plaque formation was undiminished at 39°C or 40°C, but at both temperatures, the GU viruses produced small plaques (Table 2) . This phenotype did not appear to be dependent on the size of the insert. Unexpectedly, rPIV3 bearing NCR inserts of 1404 nt or larger exhibited a ts phenotype. Also, the rPIV3/NCR viruses exhibited a small plaque phenotype at 39°C and 40°C. Another unexpected finding was that insertion of the 1908-nt GU into rcp45 L reduced its titer at 37°C and 38°C by at least 100-fold. Thus the insertion of foreign sequence conferred a slight ts phenotype to rPIV3 wt, evident by either small plaque morphology or reduction in plaque formation at 39-40°C, and augmented the level of temperature sensitivity of a virus bearing ts and att mutations. It was therefore of interest to examine the phenotype of these rPIV3 insertion mutants in vivo.
Replication of rPIV3 containing a GU or an NCR insertion in hamsters
Hamsters were inoculated intranasally (i.n.) with 10 6.0 TCID 50 of wt rPIV3, rcp45 L , or a mutant rPIV3 bearing a GU insertion (Table 3) . Lungs and nasal turbinates were harvested on day 4 after infection, and the level of replication of each virus was determined. Insertion of a GU ranging in size from 168 nt up to 1908 nt did not significantly reduce viral replication in the respiratory tract of hamsters. However, insertion of a 3918-nt gene unit between the HN and L ORF of wt PIV3 resulted in a 5-and 25-fold reduction in viral replication in the nasal turbinates and lungs, respectively. This indicates that GU insertions of this size attenuate wild-type virus, whereas shorter sizes have little effect on replication of wild-type virus in the respiratory tract of hamsters. Thus GU length is determinant of attenuation in vivo.
The r1908-nt GU ins/cp45 L , in which the 1908-nt GU insertion was combined with the cp45 L polymerase amino acid substitutions, was 20-fold more attenuated in the upper respiratory tract of hamsters (Table 3) than its rcp45 L parent virus. Considered together, these findings indicate that GU insertions of 3918 nt in length can attenuate a wild-type PIV3 virus for hamsters and that a a Source of RSV sequence is pUC118FM2, a plasmid containing a subgenomic cDNA fragment of RSV subgroup A as described previously (Juhasz et al., 1997) .
b Source of RSV sequence is D53sites, a plasmid containing the entire RSV subgroup A cDNA sequence with several introduced point mutations .
c The gel-purified 1356-nt fragment contained a 1-nt deletion compared with the predicted 1357-nt restriction endonuclease cleavage product. d The 1850-nt fragment is a product of two 3Ј-to-3Ј adjoined 925 nt restriction fragments. e Total size of each GU or NCR insertion includes the indicated RSV sequence, 58 bases in the polycloning site of GU inserts, or 32 bases in the polycloning site of NCR inserts, and as necessary an oligonucleotide 13-17 bases in length to conform the total number of inserted bases to the rule of six. Where required, one of following oligonucleotides was inserted into the MluI restriction site to adjust the length of the insert and that of the genome to be a multiple of six: 13 mer, CGCGGCAGGCCTG; 14 mer, CGCGGCGAGGCCTG; 15 mer, CGCGAGGCCTCCGCG; 16 mer, CGCGAGGC-CTCCGCGG; 17 mer, CGCGAGGCCTCCGCGGG. GU insertion half this size can augment the attenuation phenotype of a PIV3 vaccine candidate.
Hamsters were also inoculated i.n. with rPIV3 wt, rcp45 L , or a virus bearing an NCR insertion mutation (Table 4) . Lungs and nasal turbinates were harvested 4 days after inoculation, and the level of viral replication in each tissue was determined as described above. NCR insertions ranging in size from 258 nt up to 1404 nt did not significantly reduce viral replication in the respiratory tract of hamsters. However, an insertion of 3126 nt effected a 16-fold reduction in both the upper and lower respiratory tracts of infected hamsters, and a 3894-nt HN gene NCR insertion resulted in a 12-fold reduction of viral replication in the upper and lower respiratory tracts, suggesting that increasing the genome length may also have an attenuating effect on viral replication in vivo.
DISCUSSION
Mononegaviruses are potentially useful as vectors for several reasons. First, in most cases the inserts remain stably expressed even after many passages in vitro Mebatsion et al., 1996; Schnell et al., 1996a) . This differs from findings with singlestranded, positive-sense RNA viruses in which the inserts are subject to deletion (Mattion et al., 1994; Pugachev et al., 1995) . Insert stability is important for a vaccine virus because extensive replication is required for vaccine production. Second, in most cases mononegaviruses have accepted relatively large inserts without drastic reduction in replication Sakai et al., 1999; Spielhofer et al., 1998) . Third, attenuated derivatives of certain mononegaviruses are available and thus represent safe vectors (Karron et al., 1995a,b; Skiadopoulos et al., 1999c; Spielhofer et al., 1998; Whitehead et al., 1998) . Specific examples of mononegavirus vectors include (1) vesicular stomatitis virus, an animal virus, that can express the hemagglutinin (HA) or neuraminidase (NA) protein of influenza A virus, the HA or F protein of measles virus, or gp160 of human immunodeficiency virus Kretzschmar et al., 1997; Roberts et al., 1999; Schnell et al., 1996a Schnell et al., , 1997 and (2) measles virus, a human virus, that can express hepatitis B virus antigens . Finally, the mononegavirus selected to be a vector can also be a human pathogen, in which case immunity would be induced against the vector, as well as the expressed insert. This is illustrated by the above example of the measles vector expressing hepatitis B virus antigens.
An ideal mononegavirus vector would be an attenuated vaccine virus into which one or more foreign genes expressing protective antigens of another virus could be inserted without affecting its replication in vitro or its level of attenuation and immunogenicity. This ideal vector would be able to accept a variety of viral protective antigens, and its safety and immunogenicity would be predictable. Unfortunately, experience to date with mononegavirus vectors indicates that such an ideal vector has not yet been identified, because foreign gene insertions can result in decreased replication of the vector virus in vitro or in vivo depending on the size of the insert or the specific protein that is expressed Kretzschmar et al., 1997; Roberts et al., 1999; Sakai et al., 1999; Schnell et al., 1996a Schnell et al., , 1997 . Insertions that decrease replication in vitro could decrease the commercial feasibility of the vaccine and might render the vaccine virus overattenuated and poorly immunogenic. The present findings do not identify an ideal mononegavirus vector, but they do provide a framework for understanding some of the factors that affect the replication of the vector in vitro and in vivo and that should be considered in the design and in the preclinical and clinical evaluation of mononegavirus vectors.
Previous observations clearly indicated that the in vitro or in vivo replication of mononegavirus vectors could be substantially modified by the expression of specific proteins (Kretzschmar et al., 1997; Sakai et al., 1999; Schnell et al., 1996a) . Thus for any expressed foreign protective antigen, one must determine the consequences of its 
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a Plaques were enumerated by immunoperoxidase staining after incubation for 6 days at the indicated temperature. Values that are in bold represent the lowest restrictive temperature at which there was a least a 100-fold reduction of plaquing efficiency, which is defined as the shut-off temperature of plaque formation.
b Small plaques compared with plaque size at 32°C. 
a Hamsters in groups of eight were administered 10 6.0 TCID 50 of virus per animal i.n. in a 0.1-ml inoculum. Lungs and nasal turbinates were harvested 4 days later, and virus titer was determined at 32°C.
b Mean values in each column with a different letter are significantly different (␣ ϭ 0.05) by Tukey-Kramer test, whereas those with the same letter are not significantly different. 
b Mean values in each column with a different letter are significantly different (␣ ϭ 0.05) by Tukey-Kramer test, whereas those with the same letter are not significantly different.
expression on in vitro and in vivo replication. We have extended these findings by demonstrating that the length of a GU insertion, regardless of the protein expressed, can also make an independent contribution to attenuation. Thus insert size as well as the specific protein expressed must be taken into consideration in the evaluation of mononegavirus vectors. Specifically, insertion of a 3918-nt GU between the HN and L ORF of wt PIV3 resulted in a 5-and 25-fold reduction in viral replication in the nasal turbinates and lungs, respectively, indicating that GU insertions of this size are attenuating for a wild-type virus. This level of restriction in replication in the lower respiratory tract of hamsters was greater than that seen in vitro. The basis for attenuation specified by GU insertion remains to be determined. Because NCR insertions of the same size were also attenuating in and of themselves, it is possible that an increase in PIV3 genome length, rather than a disruption of the normal transcriptional gradient that occurs on insertion of a GU, was the major determinant of the decreased replication of the PIV3 vector in vivo. Both the GU and NCR insertions affected replication in vivo to a greater extent than in vitro. Thus insertion of noncoding sequences into the genome of a mononegavirus can be added to the list of types mutations that can attenuate these viruses in vivo Nagai and Kato, 1999) .
Unexpectedly, insertion of a GU of approximately 1.9 kb, which did not significantly affect the replication of wt PIV3 in vivo, augmented both the ts and att phenotypes of the attenuated PIV3 cp45 L candidate vaccine. Thus the attenuating effect of an insertion into an attenuated virus can be significantly greater than that observed when the same insert is introduced into wild-type virus.
Considered together, these observations indicate that the consequences of constructing any given recombinant mononegavirus vector vaccine remains highly empirical and that each vaccine candidate must be individually evaluated to determine whether it exhibits both efficient replication in vitro and the desired balance between attenuation and immunogenicity. Despite these constraints, the ability of rPIV3 to accommodate long heterologous sequence and the availability of attenuated derivatives of rPIV3, as well as attenuated rPIV3/PIV1 antigenic chimeric viruses, make this PIV vector system potentially useful for rapidly creating and evaluating multivalent vaccines capable of inducing an immune response to the PIV backbone itself as well as to the vectored foreign antigen.
MATERIALS AND METHODS
Viruses and cells
The rPIV3 JS wt and rcp45 L viruses that were used as controls in this study were generated previously (Durbin et al., 1997; Skiadopoulos et al., 1998) . The rPIV3s were grown in simian LLC-MK2 cells [American Type Culture Collection (ATCC) CCL 7.1] as described previously (Durbin et al., 1997; Hall et al., 1992; Skiadopoulos et al., 1998) . The modified vaccinia virus Ankara (MVA-T7) (Wyatt et al., 1995) , which expresses the T7 polymerase, was kindly provided by Linda Wyatt and Bernard Moss. HEp-2 (ATCC CCL 23) and LLC-MK2 cells were maintained in OptiMEM I (Life Technologies, Gaithersburg, MD) supplemented with 5% FBS and gentamicin sulfate (50 g/ml).
Construction of cDNAs encoding rPIV3 viruses containing GU or NCR insertions
Insertion mutations were constructed in a pUC-based plasmid, pUC118-Stu, containing an StuI restriction endonuclease recognition sequence introduced at nt 8598-8603 in the XhoI-to-SphI fragment (PIV3 nt 7437-11317) of the full-length PIV3 clone p3/7(131)2G-Stu. The StuI site was introduced by mutating the AGACAA present in the 3Ј NCR of the HN gene to AGGCCT by site-directed mutagenesis. Two separate plasmids were constructed as acceptor plasmids for the insertion of GUs and HN gene 3Ј-NCR extensions (Fig. 1) . In each, a synthetic oligonucleotide duplex containing multiple cloning sites was inserted into the unique StuI site. The inserted sequence for the GU insertion plasmid contained an HN GE signal sequence, the conserved intergenic (IG) trinucleotide sequence, and an L GS signal sequence, cisacting sequences that direct termination of the HN gene transcription and initiation of transcription of the inserted sequence (Fig. 1A) . Additional unique restriction endonuclease sites were included in the multiple cloning region to facilitate subsequent screening and subcloning. The 3Ј-NCR extension acceptor plasmid was similarly designed and constructed, but it lacked the cisacting GE, IG, and GS sequences at its 5Ј-end (Fig. 1B) . As a source of foreign sequence, the RSV antigenomic plasmid d53RSVsites or subgenomic plasmid pUC118FM2 (Juhasz et al., 1997) (Table  1) was digested with the appropriate restriction enzymes, and fragments of the desired sizes were isolated by electrophoresis on agarose gels and ligated individually into the unique HpaI site of the GU or NCR extension acceptor plasmid ( Fig. 1; Table 1 ). Clones were screened to identify those in which the RSV restriction fragments were inserted in the reverse orientation in which all reading frames contain multiple stop codons. Short synthetic oligonucleotide duplexes ranging in size from 13 to 17 nt also were inserted as necessary into the MluI site of the GU or NCR constructs to modify the genome length to conform to the rule of six (Fig. 1) . The specific RSV sequences and size of the short synthetic oligonucleotides added are summarized in Table 1 .
Plasmid clones were sequenced through all restriction enzyme sites used for subcloning, and the XhoI-SphI fragments containing the GU or NCR inserts were cloned into the full-length PIV3 wild-type cDNA plasmid p3/ 7(131)2Gϩ (Durbin et al., 1997) . In addition, the 1908 GU insert was placed into an antigenomic cDNA bearing the three ts and att L mutations of cp45 (Skiadopoulos et al., 1998) .
Recovery of rPIV3s bearing GU and NCR inserts
Full-length antigenomic cDNAs each bearing a GU or an NCR insertion were transfected together with the three support plasmids pTM(N), pTM(P no C), and pTM(L) (Durbin et al., 1997 (Durbin et al., , 1999b into HEp-2 monolayers in 6-well plates (Costar, Cambridge, MA) using LipofectACE (Life Technologies, Gaithersburg, MD), and the monolayers were infected with MVA-T7 as described previously (Durbin et al., 1997; Skiadopoulos et al., 1998) . After incubation at 32°C for 4 days, the transfection harvest was passaged onto LLC-MK2 cells in T-25 flasks that were incubated at 32°C for 4-8 days. The clarified medium supernatant was subjected to plaque purification on LLC-MK2 cells as described previously (Durbin et al., 1997; Hall et al., 1992; Skiadopoulos et al., 1998) . Each biologically cloned recombinant virus was amplified twice in LLC-MK2 cells at 32°C to produce virus for further characterization. Virus was concentrated from clarified medium by polyethylene glycol precipitation (Mbiguino and Menezes, 1991) , and viral RNA (vRNA) was extracted with Trizol Reagent (Life Technologies). Reverse transcription was performed on vRNA using the Superscript II Preamplification System (Life Technologies) with random hexamer primers. The Advantage cDNA PCR kit (Clontech, Palo Alto, CA) and sense (PIV3 nt 7108-7137) and antisense primers (PIV3 nt 10605-10576) were used to amplify PCR fragments that were analyzed by agarose gel electrophoresis and by sequencing (data not shown).
Efficiency of plaque formation of mutant rPIV3s at permissive and restrictive temperatures
The level of temperature sensitivity of plaque formation in vitro of control and recombinant viruses was determined at 32°C and at a range of temperatures from 35°C to 40°C in LLC-MK2 monolayer cultures incubated for 6 days as previously described (Hall et al., 1992; Skiadopoulos et al., 1998) . Plaques were enumerated by immunoperoxidase staining with a mixture of two PIV3-specific anti-HN murine monoclonal antibodies 101/1 and 454/11 diluted 1:250 (Murphy et al., 1990; van Wyke Coelingh et al., 1985) , and titers are expressed as log 10 plaque-forming units (PFU)/ml.
Evaluation of rPIV3 mutant viruses for the att phenotype in hamsters
Four-week-old Golden Syrian hamsters (Charles River Laboratories, NY) that were seronegative for PIV3 were inoculated i.n. with 0.1 ml of L15 medium containing 10 6.0 TCID 50 of wt rPIV3 or one of the mutant rPIV3s. On day 4 postinfection, the lungs and nasal turbinates were harvested, and the virus was quantified as previously described (Skiadopoulos et al., 1998) . The mean log 10 TCID 50 /g at 32°C was calculated for each group of hamsters.
Multicycle growth curves
Each PIV3 was inoculated in triplicate into LLC-MK2 monolayers in 6-well plates at a multiplicity of infection of 0.01, and cultures were incubated at 32°C, as described previously . Then 0.5 ml of medium from each well was harvested and replaced with 0.5 ml of fresh medium at 0 and 24 h intervals thereafter for 6 days postinfection. Harvested samples were stored at Ϫ80°C. Virus present in the samples was quantified by TCID 50 on LLC-MK2 monolayers in 96-well plates and incubated at 32°C. Virus was detected by hemadsorption and reported as mean log 10 TCID 50 /ml.
